Syntheses and in vitro evaluation of decalinvesamicol analogues as potential imaging probes for vesicular acetylcholine transporter (VAChT). 2012

Takashi Kozaka, and Izumi Uno, and Yoji Kitamura, and Daisuke Miwa, and Kazuma Ogawa, and Kazuhiro Shiba
Division of Tracer Kinetics, Advanced Science Research Center, Kanazawa University, 13-1 Takara-machi, Kanazawa, Ishikawa 920-8640, Japan. t-kozaka@staff.kanazawa-u.ac.jp

A series of vesamicol analogues, o-iodo-trans-decalinvesamicol (OIDV) or o-bromo-trans-decalinvesamicol (OBDV), were synthesized and their affinities to vesicular acetylcholine transporter (VAChT) and σ receptors (σ-1, σ-2) were evaluated by in vitro binding assays using rat cerebral or liver membranes. OIDV and OBDV showed greater binding affinity to VAChT (K(i) = 20.5 ± 5.6 and 13.8 ± 1.2 nM, respectively) than did vesamicol (K(i) = 33.9 ± 18.1 nM) with low affinity to σ receptors. A saturation binding assay in rat cerebral membranes revealed that [(125)I]OIDV had a single high affinity binding site with a K(d) value of 1.73 nM and a B(max) value of 164.4 fmol/mg protein. [(125)I]OIDV revealed little competition with inhibitors, which possessed specific affinity to each σ (σ-1 and σ-2), serotonin (5-HT(1A) and 5-HT(2A)), noradrenaline, and muscarinic acetylcholine receptors. In addition, BBB penetration of [(125)I]OIDV was verified in in vivo. The results of the binding studies indicated that OIDV and OBDV had great potential to be VAChT imaging probes with high affinity and selectivity.

UI MeSH Term Description Entries
D008297 Male Males
D010880 Piperidines A family of hexahydropyridines.
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular
D017207 Rats, Sprague-Dawley A strain of albino rat used widely for experimental purposes because of its calmness and ease of handling. It was developed by the Sprague-Dawley Animal Company. Holtzman Rat,Rats, Holtzman,Sprague-Dawley Rat,Rats, Sprague Dawley,Holtzman Rats,Rat, Holtzman,Rat, Sprague-Dawley,Sprague Dawley Rat,Sprague Dawley Rats,Sprague-Dawley Rats
D017480 Receptors, sigma A class of cell surface receptors recognized by its pharmacological profile. Sigma receptors were originally considered to be opioid receptors because they bind certain synthetic opioids. However they also interact with a variety of other psychoactive drugs, and their endogenous ligand is not known (although they can react to certain endogenous steroids). Sigma receptors are found in the immune, endocrine, and nervous systems, and in some peripheral tissues. Opioid Receptors, sigma,Receptors, Opioid, sigma,Receptors, sigma Opioid,sigma Receptors,sigma Receptor,Receptor, sigma,sigma Opioid Receptors
D050494 Vesicular Acetylcholine Transport Proteins Vesicular amine transporter proteins that transport the neurotransmitter ACETYLCHOLINE into small SECRETORY VESICLES. Proteins of this family contain 12 transmembrane domains and exchange vesicular PROTONS for cytoplasmic acetylcholine. Acetylcholine Transporters, Vesicular,Vesicular Acetylcholine Transporter Proteins,VAChT Proteins,Vesicular Acetylcholine Transporter,Acetylcholine Transporter, Vesicular,Transporter, Vesicular Acetylcholine,Transporters, Vesicular Acetylcholine,Vesicular Acetylcholine Transporters
D051381 Rats The common name for the genus Rattus. Rattus,Rats, Laboratory,Rats, Norway,Rattus norvegicus,Laboratory Rat,Laboratory Rats,Norway Rat,Norway Rats,Rat,Rat, Laboratory,Rat, Norway,norvegicus, Rattus
D019275 Radiopharmaceuticals Compounds that are used in medicine as sources of radiation for radiotherapy and for diagnostic purposes. They have numerous uses in research and industry. (Martindale, The Extra Pharmacopoeia, 30th ed, p1161) Radiopharmaceutical

Related Publications

Takashi Kozaka, and Izumi Uno, and Yoji Kitamura, and Daisuke Miwa, and Kazuma Ogawa, and Kazuhiro Shiba
February 2005, Bioorganic & medicinal chemistry,
Takashi Kozaka, and Izumi Uno, and Yoji Kitamura, and Daisuke Miwa, and Kazuma Ogawa, and Kazuhiro Shiba
November 2010, Bioorganic & medicinal chemistry,
Takashi Kozaka, and Izumi Uno, and Yoji Kitamura, and Daisuke Miwa, and Kazuma Ogawa, and Kazuhiro Shiba
January 2010, Current topics in medicinal chemistry,
Takashi Kozaka, and Izumi Uno, and Yoji Kitamura, and Daisuke Miwa, and Kazuma Ogawa, and Kazuhiro Shiba
September 1997, Neuroreport,
Takashi Kozaka, and Izumi Uno, and Yoji Kitamura, and Daisuke Miwa, and Kazuma Ogawa, and Kazuhiro Shiba
November 2020, Synapse (New York, N.Y.),
Takashi Kozaka, and Izumi Uno, and Yoji Kitamura, and Daisuke Miwa, and Kazuma Ogawa, and Kazuhiro Shiba
September 2018, ChemMedChem,
Takashi Kozaka, and Izumi Uno, and Yoji Kitamura, and Daisuke Miwa, and Kazuma Ogawa, and Kazuhiro Shiba
January 1998, Advances in pharmacology (San Diego, Calif.),
Takashi Kozaka, and Izumi Uno, and Yoji Kitamura, and Daisuke Miwa, and Kazuma Ogawa, and Kazuhiro Shiba
January 1998, Journal of anatomy,
Takashi Kozaka, and Izumi Uno, and Yoji Kitamura, and Daisuke Miwa, and Kazuma Ogawa, and Kazuhiro Shiba
December 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology,
Takashi Kozaka, and Izumi Uno, and Yoji Kitamura, and Daisuke Miwa, and Kazuma Ogawa, and Kazuhiro Shiba
September 2009, Bioorganic & medicinal chemistry letters,
Copied contents to your clipboard!